In vivo trial comparing patients' tolerance of Q-switched alexandrite (QS Alex) and Q-switched neodymium : yttrium-aluminum-garnet (QS Nd : YAG) lasers in the treatment of nevus of Ota
Hhl. Chan et al., In vivo trial comparing patients' tolerance of Q-switched alexandrite (QS Alex) and Q-switched neodymium : yttrium-aluminum-garnet (QS Nd : YAG) lasers in the treatment of nevus of Ota, LASER SURG, 24(1), 1999, pp. 24-28
Background and Objectives: Different types of Q-switched lasers have been f
ound to be effective in the treatment of nevus of Ota. However, a clinical
trial involving in vivo comparison of the use of different laser systems ha
s not been performed. The aim of the present study was to compare the patie
nt tolerance of Q-switched Alexandrite (QS Alex) and Q-switched neodymium:y
ttrium-aluminum-garnet (QS Nd:YAG) lasers in the treatment of nevus of Ota.
Study Design/Materials and Methods: Thirty-three patients (11 male, 22 fema
le) were recruited for this study, and 45 treatment sessions were performed
. Half of each lesion was treated with QS Alex and the other half with QS N
d:YAG; laser. Patients were interviewed with a visual analog scale question
naire immediately after treatment and 1 week later. Questions included the
degree of pain, swelling, and bleeding.
Results: The immediate pain after treatment was more severe for QS Alex tha
n for QS Nd:YAG; laser. However, 1 week after laser therapy, most patients
found QS Alex to be superior.
Conclusion: Patients tolerate QS-Alex better than QS Nd:YAC;. This finding
is important because patients with nevus of Ota are often children, and mul
tiple laser sessions are necessary for complete resolution of the lesion. L
asers Surg. Med. 24:24-28, 1999. (C) 1999 Wiley-Liss, Inc.